LEADER 03192nam a22006255i 4500
001 822923
003 TR_AnAIT
005 20260130154413
007 cr nn 008mamaa
008 151211s2008 xxk| s |||| 0|eng d
020 |a9780230584044|9978-0-230-58404-4
024 7 |a10.1057/9780230584044|2doi
041 |aeng
049 |aTürk Tarih Kurumu Kütüphanesi
050 4|aJN1-9692.2
072 7|aJP|2bicssc
072 7|a1D|2bicssc
072 7|aPOL058000|2bisacsh
072 7|aJP|x1D|2thema
082 04|a320.94|223
090 |aDK/24067
100 1 |aKrapohl, Sebastian.|eauthor.|4aut|4http://id.loc.gov/vocabulary/relators/aut
245 10|aRisk Regulation in the Single Market|h[electronic resource] :|bThe Governance of Pharmaceuticals and Foodstuffs in the European Union /|cby Sebastian Krapohl.
250 |a1st ed. 2008.
264 1|aLondon :|bPalgrave Macmillan UK :|bImprint: Palgrave Macmillan,|c2008.
300 |aXIII, 225 p.|bonline resource.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
347 |atext file|bPDF|2rda
490 1 |aPalgrave Studies in European Union Politics,|x2662-5881
520 |aThis book demonstrates how the Thalidomide catastrophe of the 1960s and the BSE crisis of the 1990s led to regulatory regimes for pharmaceuticals and foodstuffs in Europe. However, the developmental paths of these regimes differ – and so does the efficiency and legitimacy of regulatory policy-making.
532 8 |aAccessibility summary: This PDF is not accessible. It is based on scanned pages and does not support features such as screen reader compatibility or described non-text content (images, graphs etc). However, it likely supports searchable and selectable text based on OCR (Optical Character Recognition). Users with accessibility needs may not be able to use this content effectively. Please contact us at accessibilitysupport@springernature.com if you require assistance or an alternative format.
532 8 |aInaccessible, or known limited accessibility
532 8 |aNo reading system accessibility options actively disabled
532 8 |aPublisher contact for further accessibility information: accessibilitysupport@springernature.com
650 0|aEurope|xPolitics and government.
650 0|aInternational economic relations.
650 0|aPolitical science.
650 0|aBiotechnology.
650 0|aIndustries.
650 14|aEuropean Politics.
650 24|aInternational Political Economy’.
650 24|aPolitical Science.
650 24|aChemical Bioengineering.
650 24|aIndustries.
650 24|aBiotechnology.
710 2 |aSpringerLink (Online service)
773 0 |tSpringer Nature eBook
776 08|iPrinted edition:|z9780230537651
776 08|iPrinted edition:|z9781349359356
776 08|iPrinted edition:|z9781349359363
830 0|aPalgrave Studies in European Union Politics,|x2662-5881
856 40|uhttps://doi.org/10.1057/9780230584044
912 |aZDB-2-PIS
912 |aZDB-2-SXPI
950 |aPalgrave Political & Intern. Studies Collection (SpringerNature-41143)
950 |aPolitical Science and International Studies (R0) (SpringerNature-43724)